The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunotherapy versus targeted therapy in the adjuvant setting for resected stage III melanoma: A single institution study.
 
Danai Dima
No Relationships to Disclose
 
Nerea Lopetegui-Lia
No Relationships to Disclose
 
Olisaemeka Ogbue
No Relationships to Disclose
 
Bennett Osantowski
No Relationships to Disclose
 
Ramsha Ahmed
No Relationships to Disclose
 
Diana Basali
No Relationships to Disclose
 
Fatimah Chamseddine
No Relationships to Disclose
 
Donald Matthew Eicher
No Relationships to Disclose
 
Jung Min Song
No Relationships to Disclose
 
Brian Gastman
Stock and Other Ownership Interests - Castle Biosciences
Consulting or Advisory Role - Castle Biosciences; Quest Imaging
Speakers' Bureau - Castle Biosciences
Research Funding - Alkermes; Instil Bio; Merck; NeoImmuneTech; Quest Imaging
Travel, Accommodations, Expenses - Alkermes
 
Lucy Boyce Kennedy
No Relationships to Disclose
 
Pauline Funchain
Consulting or Advisory Role - Eisai; GigaGen; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Taiho Oncology (Inst)